On March 4, 2019 MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX & MDAX; Nasdaq: MOR) reported that it will publish its Annual Financial Results 2018 on March 13, 2019 at 10:00pm CET (9:00pm GMT; 5:00pm EDT) (Press release, MorphoSys, MAR 4, 2019, View Source [SID1234533921]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Management team of MorphoSys AG will host a conference call and webcast on March 14, 2019 at 2:00pm CET (1:00pm GMT; 9:00am EDT) to present MorphoSys’s Annual Financial Results 2018 and provide an outlook for 2019.

Date of the conference call: Thursday, March 14, 2019
Time: 2:00pm CET (1:00pm GMT, 9:00am EDT)
Dial-in numbers (listen only)
Germany: +49 69 201 744 220
United Kingdom: +44 203 009 2470
USA: +1 877 423 0830
Participant PIN: 88207738#

Company participants in the call will be:

Dr. Simon Moroney, Chief Executive Officer
Jens Holstein, Chief Financial Officer
Dr. Malte Peters, Chief Development Officer
Dr. Markus Enzelberger, Chief Scientific Officer

Participants are kindly requested to dial in up to 10 minutes before the call to ensure a secure line and a prompt start.

The presentation slides and webcast link will be available at the Company’s website at View Source

A replay of the conference will also be available at the corporate website following the live event.